FDA to enter drug business under new "Revitalization Act"

This Revitalization Act, it turns out, seeks to create a new government-run pharmaceutical company headed by officials from the FDA. It would officially and unambigiously put the U.S. government in the drug business, where it could license pharmaceuticals and collect royalties on their sale. For obvious reasons, this is a particularly dangerous situation for consumers. Government should be regulating drug companies, not joining them as partners in profit.

A new attack against health freedom, drug safety, and dietary supplements was launched last week by Senator Edward Kennedy (D-MA) with major support from Michael Enzi (R-WY). It is called the Food and Drug Administration Revitalization Act (S1082). This legislation was planned over the past few years working hand-in-glove with the FDA’s dysfunctional management and legal team – meaning this legislation was written for the profits of Big Pharma and Big Biotech AT THE EXPENSE OF SAFETY AND HUMAN HEALTH.

S1082 is a Trojan Horse bill that pretends to address safety issues. Unbelievably, the bill turns the FDA into a drug development company that will expose Americans to new and dangerous biological drugs that have little testing to prove safety or effectiveness. And to top it off, the bill gives broad new regulatory powers to the FDA that can be used to frivolously attack dietary supplements and forward the FDA management’s anti-American globalization agenda.

WASHINGTON (Reuters) - The U.S. Food and Drug Administration issued a new report on Tuesday describing potential risks of several medicines after criticism that it was lax in policing drugs once they were on the market.